摘要
自基因治疗的初期起,在酶缺乏和肌肉疾病的修正治疗方面肌肉一直是研究最多的靶组织之一。现已进行了一些腺相关病毒(AAV)载体的临床前和临床研究,并已在基因转移技术上取得了可喜的进展,从对血清型新型AVV的识别到新型载体转移技术的发展。同时,在宿主免疫系统及其与载体和转入基因在肌肉水平上的相互作用等方面也取得了重大突破。特别是,潜在肌肉炎症的作用,影响肌肉的几种疾病的特点,已在对AVV载体基因转移的潜在不利影响方面得到确认。同时,骨骼肌涉及的驻留的调节T细胞特有的反馈免疫调节机制已被确定,至少在某种程度上,对维持肌肉炎症和再生过程中肌肉内稳态发挥着重要作用。设计一些策略来打破机体(免疫系统)的无反应性平衡,以改善通过AAV载体进行肌肉基因转移的安全性和有效性。
关键词: AVV载体(腺相关病毒载体),肌肉,临床试验,免疫反应,耐受性
Current Gene Therapy
Title:The Skeletal Muscle Environment and Its Role in Immunity and Tolerance to AAV Vector-Mediated Gene Transfer
Volume: 15 Issue: 4
Author(s): Florence Boisgerault and Federico Mingozzi
Affiliation:
关键词: AVV载体(腺相关病毒载体),肌肉,临床试验,免疫反应,耐受性
摘要: Since the early days of gene therapy, muscle has been one the most studied tissue targets for the correction of enzyme deficiencies and myopathies. Several preclinical and clinical studies have been conducted using adeno-associated virus (AAV) vectors. Exciting progress has been made in the gene delivery technologies, from the identification of novel AAV serotypes to the development of novel vector delivery techniques. In parallel, significant knowledge has been generated on the host immune system and its interaction with both the vector and the transgene at the muscle level. In particular, the role of underlying muscle inflammation, characteristic of several diseases affecting the muscle, has been defined in terms of its potential detrimental impact on gene transfer with AAV vectors. At the same time, feedback immunomodulatory mechanisms peculiar of skeletal muscle involving resident regulatory T cells have been identified, which seem to play an important role in maintaining, at least to some extent, muscle homeostasis during inflammation and regenerative processes. Devising strategies to tip this balance towards unresponsiveness may represent an avenue to improve the safety and efficacy of muscle gene transfer with AAV vectors.
Export Options
About this article
Cite this article as:
Florence Boisgerault and Federico Mingozzi , The Skeletal Muscle Environment and Its Role in Immunity and Tolerance to AAV Vector-Mediated Gene Transfer, Current Gene Therapy 2015; 15 (4) . https://dx.doi.org/10.2174/1566523215666150630121750
DOI https://dx.doi.org/10.2174/1566523215666150630121750 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Potential Role of Statins in Pneumonia
Current Respiratory Medicine Reviews MMP-9 Inhibitors in the Brain: Can Old Bullets Shoot New Targets?
Current Pharmaceutical Design Modulation of Eosinophil Functions by Nitric Oxide: Cyclic GMPdependent and -independent Mechanisms
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Vascular Effects of Estrogenic Menopausal Hormone Therapy
Reviews on Recent Clinical Trials New Therapies in SLE
Recent Patents on Inflammation & Allergy Drug Discovery Hypersensitivity Reactions to Quinolones
Current Pharmaceutical Design Mechanisms of Corticosteroid Resistance in Severe Asthma and Chronic Obstructive Pulmonary Disease (COPD)
Current Pharmaceutical Design Brown Recluse Spider Venom: Proteomic Analysis and Proposal of a Putative Mechanism of Action
Protein & Peptide Letters The role of interleukin 35 in atherosclerosis
Current Pharmaceutical Design Biosafety of Adenoviral Vectors
Current Gene Therapy Food-Derived Peptides and Intestinal Functions
Current Pharmaceutical Design Management of Connective Tissue Interstitial Lung Disease
Current Respiratory Medicine Reviews Meet Our Editorial Board Member:
Current Rheumatology Reviews A Review on Natural Products for Controlling Type 2 Diabetes with an Emphasis on their Mechanisms of Actions
Current Diabetes Reviews Fc Receptors as Potential Targets for the Treatment of Allergy, Autoimmune Disease and Cancer
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Oncolytic Virotherapy for Breast Cancer Treatment
Current Gene Therapy Platelet Activation in Atherogenesis Associated with Low-Grade Inflammation
Inflammation & Allergy - Drug Targets (Discontinued) The Immune Protective Effect of the Mediterranean Diet against Chronic Low-grade Inflammatory Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Mixed Connective Tissue Disease, a Roundabout to Rheumatic Diseases?
Current Rheumatology Reviews Rashes, Sniffles, and Stroke: A Role for Infection in Ischemic Stroke of Childhood
Infectious Disorders - Drug Targets